Santen Pharmaceutical

(OTC) SNPHF

Current Price$10.87

Market Cap$3.54B

Since IPO (2004)-30%

5 Year-6%

1 Year+7%

1 Month+16%

Santen Pharmaceutical Financials at a Glance

Market Cap

$3.54B

Revenue (TTM)

$293.18B

Net Income (TTM)

$37.58B

EPS (TTM)

$0.75

P/E Ratio

14.67

Dividend

$0.25

Beta (Volatility)

0.06 (Low)

Dividend

$0.25

Beta (Volatility)

0.06 (Low)

Price

$10.87

Volume

2,022

Open

$10.87

Price

$10.87

Volume

2,022

Open

$10.87

Previous Close

$10.87

Daily Range

$10.87 - $10.87

52-Week Range

$8.88 - $11.45

Dividend

$0.25

Beta (Volatility)

0.06 (Low)

Price

$10.87

Volume

2,022

Open

$10.87

Previous Close

$10.87

Daily Range

$10.87 - $10.87

52-Week Range

$8.88 - $11.45

SNPHF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Santen Pharmaceutical

Industry

Pharmaceuticals

Sector

Health Care

Employees

3,849

CEO

Takeshi Ito

Website

www.santen.co.jp

Headquarters

Osaka, 530-8552, JP

SNPHF Financials

Key Financial Metrics (TTM)

Gross Margin

55%

Operating Margin

16%

Net Income Margin

13%

Return on Equity

13%

Return on Capital

13%

Return on Assets

Earnings Yield

6.82%

Dividend Yield

2.25%

Payout Ratio

33.84%

Stock Overview

Market Cap

$3.54B

Shares Outstanding

321.68M

Volume

2.02K

Avg. Volume

38.71

Financials (TTM)

Gross Profit

$161.98B

Operating Income

$45.50B

EBITDA

$63.97B

Operating Cash Flow

$43.77B

Capital Expenditure

$6.89B

Free Cash Flow

$36.89B

Cash & ST Invst.

$81.38B

Total Debt

$0.00

Santen Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

$81.37B

+5.4%

Gross Profit

$49.98B

+8.4%

Gross Margin

61.43%

N/A

Market Cap

$3.54B

N/A

Market Cap/Employee

$944.24K

N/A

Employees

3,744

N/A

Net Income

$15.64B

+77.9%

EBITDA

$21.76B

+17.7%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Net Cash

$81.38B

+36.2%

Accounts Receivable

$72.28B

+0.7%

Inventory

$64.99B

+26.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

8.83%

N/A

Return on Invested Capital

13.49%

N/A

Free Cash Flow

$19.21B

+6.9%

Operating Cash Flow

$21.11B

+11.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CAMRFCamurus AB (publ)

CAMRFCamurus AB (publ)$63.30+0.00%

BUHPFBumrungrad Hospital Public Company Limited

BUHPFBumrungrad Hospital Public Company Limited$5.45+0.00%

CZMWYCarl Zeiss Meditec AG

CZMWYCarl Zeiss Meditec AG$29.91+2.54%

CZMWFCarl Zeiss Meditec AG

CZMWFCarl Zeiss Meditec AG$29.86+2.19%

DNPUFSumitomo Pharma Co., Ltd.

DNPUFSumitomo Pharma Co., Ltd.$10.15-5.14%

OPHLYOno Pharmaceutical Co., Ltd.

OPHLYOno Pharmaceutical Co., Ltd.$5.07+1.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$12.95+0.07%

NOKNokia

NOKNokia$13.62-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.51+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.67+0.06%

NUNu Holdings

NUNu Holdings$12.79+0.04%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.19-0.05%

POETPoet Technologies

POETPoet Technologies$14.78+0.13%

Questions About SNPHF

What is the current price of Santen Pharmaceutical?

Santen Pharmaceutical is trading at $10.87 per share.

What is the 52-week range for Santen Pharmaceutical?

Over the past 52 weeks, Santen Pharmaceutical has traded between $8.88 and $11.45.

How much debt does Santen Pharmaceutical have?

As of the most recent reporting period, Santen Pharmaceutical reported total debt of $230.60M.

How much cash does Santen Pharmaceutical have on hand?

Santen Pharmaceutical reported $508.36M in cash and cash equivalents in its most recent financial results.

What is Santen Pharmaceutical’s dividend yield?

Santen Pharmaceutical currently has a dividend yield of 2.25%.

Santen Pharmaceutical

Santen Pharmaceutical Financials at a Glance

SNPHF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Santen Pharmaceutical

SNPHF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Santen Pharmaceutical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SNPHF

What is the current price of Santen Pharmaceutical?

What is the 52-week range for Santen Pharmaceutical?

How much debt does Santen Pharmaceutical have?

How much cash does Santen Pharmaceutical have on hand?

What is Santen Pharmaceutical’s dividend yield?

Premium Investing Services